Go Pro

Yigal Nochomovitz Analyst Performance

Director, Biotech Equity Research at Citigroup

Yigal Nochomovitz is a stock analyst at Citigroup focused in the healthcare sector, covering 51 publicly traded companies. Over the past year, Yigal Nochomovitz has issued 120 stock ratings, including buy, hold, and sell recommendations. While full access to Yigal Nochomovitz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yigal Nochomovitz's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
189 Last 11 Years
Buy Recommendations
82.97% 151 Buy Ratings
Companies Covered
51 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.0%151 ratings
Hold13.2%24 ratings
Sell3.8%7 ratings

Out of 182 total stock ratings issued by Yigal Nochomovitz at Citigroup, the majority (83.0%) have been Buy recommendations, followed by 13.2% Hold and 3.8% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.1% of companies on NASDAQ
49 companies
NYSE
2.0% of companies on NYSE
1 company
OTCMKTS
2.0% of companies on OTCMKTS
1 company

Yigal Nochomovitz, an analyst at Citigroup, currently covers 51 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
50 companies
98.0%
Miscellaneous
1 company
2.0%

Yigal Nochomovitz of Citigroup specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
38 companies
74.5%
PHARMACEUTICALS
11 companies
21.6%
Miscellaneous
1 company
2.0%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
2.0%

Yigal Nochomovitz's Ratings History at Citigroup

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/3/2026Boost Price Target$158.42$253.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
9/3/2026Lower Price Target$14.89$28.00Buy
ATTO
Attovia Therapeutics
8/31/2026Initiated Coverage$20.70$30.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/27/2026Reiterated Rating$98.51Market Outperform
Zymeworks Inc. stock logo
ZYME
Zymeworks
8/26/2026Boost Price Target$29.11$38.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
8/25/2026Reiterated Rating$57.08Market Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
8/25/2026Boost Price Target$30.39$40.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
8/20/2026Boost Price Target$25.33$58.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
8/18/2026Lower Price Target$5.34$17.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
8/13/2026Lower Price Target$31.46$40.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
8/12/2026Reiterated Rating$5.21Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/11/2026Lower Price Target$10.25$59.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
8/10/2026Lower Price Target$8.75$21.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
8/10/2026Boost Price Target$29.21$39.00Buy
Ardelyx, Inc. stock logo
ARDX
Ardelyx
8/10/2026Lower Price Target$4.01$11.00Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
8/7/2026Boost Price Target$20.88$45.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
8/6/2026Reiterated Rating$40.48Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/6/2026Reiterated Rating$105.79Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
8/5/2026Boost Price Target$56.02$85.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
8/5/2026Reiterated Rating$27.15Market Outperform
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/4/2026Boost Price Target$312.57$386.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
8/4/2026Boost Price Target$49.57$88.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2026Boost Price Target$166.80$249.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
7/22/2026Reiterated Rating$48.15Market Outperform
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
7/21/2026Initiated Coverage$298.26$387.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/29/2026Boost Price Target$25.32$35.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
6/15/2026Reiterated Rating$99.35Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
6/15/2026Boost Price Target$53.54$70.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
6/5/2026Upgrade$4.80$7.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
6/3/2026Boost Price Target$45.08$62.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
6/3/2026Reiterated Rating$17.13Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
6/2/2026Initiated Coverage$96.33$145.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/27/2026Reiterated Rating$51.59Market Outperform
Seaport Therapeutics, Inc. stock logo
SPTX
Seaport Therapeutics
5/26/2026Initiated Coverage$17.50$35.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
5/18/2026Initiated Coverage$10.18$21.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
5/18/2026Initiated Coverage$9.15$21.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
5/14/2026Reiterated Rating$19.93Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
5/13/2026Reiterated Rating$29.37$81.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
5/13/2026Lower Price Target$28.91$43.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
5/13/2026Lower Price Target$7.93$20.00Buy
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)

A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel

Click here to learn this company's name for free today
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
5/11/2026Boost Price Target$2.36$3.10Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
5/8/2026Lower Price Target$18.63$44.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
5/8/2026Lower Price Target$22.40$32.00Buy
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
5/7/2026Lower Price Target$26.24$69.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/6/2026Boost Price Target$52.38$82.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2026Boost Price Target$144.93$246.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
5/5/2026Boost Price Target$44.91$59.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/5/2026Boost Price Target$284.93$378.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
5/5/2026Initiated Coverage$1.48Outperform
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
5/5/2026Lower Price Target$9.26$16.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
5/4/2026Boost Price Target$10.51$24.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
4/24/2026Boost Price Target$31.14$45.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
4/15/2026Boost Price Target$225.09$282.00Buy
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
4/14/2026Boost Price Target$30.70$53.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/7/2026Boost Price Target$131.09$242.00Buy
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
4/1/2026Reiterated Rating$40.40$41.00Neutral
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/31/2026Downgrade$40.39Hold
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
3/27/2026Boost Price Target$1.33$7.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/26/2026Boost Price Target$21.84$13.00Sell
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
3/26/2026Lower Price Target$8.66$26.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
3/24/2026Boost Price Target$198.87$276.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/19/2026Boost Price Target$10.79$21.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
3/17/2026Lower Price Target$23.46$41.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/17/2026Boost Price Target$15.22$62.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
3/13/2026Lower Price Target$4.67$22.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
3/13/2026Boost Price Target$5.99$7.00Neutral
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
3/11/2026Boost Price Target$6.80$9.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/10/2026Boost Price Target$17.95$9.00Sell
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/10/2026Boost Price Target$1.69$2.30Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3/9/2026Boost Price Target$15.56$35.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/6/2026Boost Price Target$23.90$33.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/5/2026Boost Price Target$13.62$18.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
3/5/2026Boost Price Target$21.88$45.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
3/4/2026Boost Price Target$7.58$8.00Neutral
Spyglass Pharma, Inc. stock logo
SGP
Spyglass Pharma
3/3/2026Initiated Coverage$26.73$42.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/2/2026Boost Price Target$22.00$57.00Buy
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
2/25/2026Lower Price Target$21.18$44.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/24/2026Boost Price Target$11.71$17.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
2/24/2026Reiterated Rating$16.09Buy
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
2/19/2026Boost Price Target$30.92$65.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/18/2026Boost Price Target$287.84$371.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/16/2026Reiterated Rating$53.07Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Boost Price Target$123.30$204.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
1/30/2026Reiterated Rating$15.40Market Outperform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
1/30/2026Reiterated Rating$53.35Market Outperform
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
1/12/2026Boost Price Target$272.12$336.00Buy
Ardelyx, Inc. stock logo
ARDX
Ardelyx
1/9/2026Boost Price Target$7.00$14.00Buy
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
1/6/2026Boost Price Target$3.89$4.00Neutral
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
1/6/2026Boost Price Target$26.15$36.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
1/6/2026Upgrade$244.71$309.00Buy
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

Arvinas, Inc. stock logo
ARVN
Arvinas
1/6/2026Upgrade$11.17$15.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
1/6/2026Lower Price Target$6.52$7.00Neutral
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
12/17/2025Reiterated Rating$5.82Market Outperform
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
12/12/2025Reiterated Rating$21.58Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
12/12/2025Boost Price Target$31.58$60.00Buy
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
12/10/2025Lower Price Target$4.80$7.00Buy
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
12/9/2025Initiated Coverage$184.67$270.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
12/3/2025Initiated Coverage$25.10Outperform
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/17/2025Boost Price Target$11.99$16.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
11/14/2025Lower Price Target$4.65$24.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
11/13/2025Lower Price Target$7.91$9.00Neutral
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
11/11/2025Reiterated Rating$54.58$77.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
11/11/2025Lower Price Target$19.21$31.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
11/10/2025Lower Price Target$1.37$6.00Buy
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
11/10/2025Boost Price Target$329.20$405.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
11/5/2025Lower Price Target$3.93$14.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
11/4/2025Boost Price Target$197.85$198.00Neutral
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
11/3/2025Boost Price Target$2.93$8.00Buy
Ardelyx, Inc. stock logo
ARDX
Ardelyx
11/3/2025Boost Price Target$5.88$11.00Buy
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
10/31/2025Lower Price Target$21.47$45.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
10/29/2025Boost Price Target$135.35$203.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
10/29/2025Boost Price Target$20.23$56.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
10/28/2025Boost Price Target$30.00$46.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
10/23/2025Downgrade$11.54$12.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
10/21/2025Initiated Coverage$141.33$175.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
10/21/2025Initiated Coverage$20.94$33.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
10/20/2025Boost Price Target$20.99$40.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
10/13/2025Boost Price Target$14.70$54.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
10/10/2025Reiterated Rating$19.68Buy
Merus N.V. stock logo
MRUS
Merus
9/29/2025Downgrade$68.89$97.00Neutral
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
8/12/2025Reiterated Rating$17.42$33.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
8/12/2025Reiterated Rating$11.39$49.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/12/2025Boost Price Target$4.57$21.00Buy
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
8/11/2025Reiterated Rating$34.96$69.00Buy
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
8/11/2025Lower Price Target$1.55$7.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
8/11/2025Boost Price Target$11.94$22.00Buy
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
8/7/2025Boost Price Target$1.12$1.90Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
8/5/2025Boost Price Target$12.59$51.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/5/2025Reiterated Rating$135.38$166.00Neutral
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
7/31/2025Reiterated Rating$30.58$49.00Buy
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
7/29/2025Boost Price Target$18.50$46.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/22/2025Initiated Coverage$13.32Sell
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
7/16/2025Lower Price Target$1.87$9.00Buy
ProKidney Corp. stock logo
PROK
ProKidney
7/9/2025Reiterated Rating$4.70$9.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
6/26/2025Initiated Coverage$4.74$14.00Buy
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
5/22/2025Lower Price Target$17.49$41.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/16/2025Lower Price Target$130.60$155.00Neutral
Arvinas, Inc. stock logo
ARVN
Arvinas
5/5/2025Lower Price Target$7.63$9.50Neutral
Ardelyx, Inc. stock logo
ARDX
Ardelyx
5/2/2025Lower Price Target$4.13$10.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
3/26/2025Set Price Target$15.86$35.00
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
3/20/2025Boost Price Target$26.29$47.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/7/2025Boost Price Target$12.00$19.00Buy
Arvinas, Inc. stock logo
ARVN
Arvinas
3/7/2025Lower Price Target$18.28$19.00Neutral
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
3/6/2025Boost Price Target$20.18$55.00Buy
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/4/2025Lower Price Target$14.48$42.00Buy
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
2/20/2025Initiated Coverage$10.47$25.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/20/2025Boost Price Target$181.64$215.00Neutral
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/18/2025Lower Price Target$52.29$82.00Buy